MoneyWorks4Me

Everest Organics - Quaterly Results

28 May 2025 Evaluate
A decrease in the sales to Rs. 409.35 millions was observed for the quarter ended March 2025. The sales stood at Rs. 526.17 millions during the similar quarter previous year.Net Profit for the quarter ended March 2025 zoomed to 4920.69% from Rs. 0.58 millions to Rs. 29.12  millions.Operating Profit saw a handsome growth to 36.53 millions from 32.57 millions in the quarter ended March 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 409.35 526.17 -22.20 1594.79 1972.41 -19.15 1594.79 1972.41 -19.15
Other Income 2.16 2.97 -27.27 6.87 8.86 -22.46 6.87 8.86 -22.46
PBIDT 36.53 32.57 12.16 79.10 118.73 -33.38 79.10 118.73 -33.38
Interest 11.47 12.43 -7.72 51.90 54.66 -5.05 51.90 54.66 -5.05
PBDT 25.06 20.14 24.43 27.20 64.07 -57.55 27.20 64.07 -57.55
Depreciation 15.58 18.52 -15.87 59.62 57.96 2.86 59.62 57.96 2.86
PBT 9.48 1.62 485.19 -32.42 6.11 -630.61 -32.42 6.11 -630.61
TAX -19.64 1.04 -1988.46 -19.52 4.71 -514.44 -19.52 4.71 -514.44
Deferred Tax -19.64 0.74 -2754.05 -19.52 3.71 -626.15 -19.52 3.71 -626.15
PAT 29.12 0.58 4920.69 -12.90 1.40 -1021.43 -12.90 1.40 -1021.43
Equity 97.10 80.00 21.37 97.10 80.00 21.37 97.10 80.00 21.37
PBIDTM(%) 8.92 6.19 44.17 4.96 6.02 -17.60 4.96 6.02 -17.60
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..